Shareholdings
| Concept |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
As at 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholdings | ||||||||||||||||||||||
| Reporting company | ||||||||||||||||||||||
| Details of specified investment shares held for purposes other than pure investment | ||||||||||||||||||||||
| Issue |
㈱コスモス薬品
|
ウエルシアホールディングス㈱
|
㈱ツルハホールディングス
|
MS&ADインシュアランス グループ ホールディングス㈱
|
ゼリア新薬工業㈱
|
㈱三菱UFJフィナンシャル・グループ
|
㈱あらた
|
アステナホールディングス㈱ （注３）
|
㈱三越伊勢丹ホールディングス
|
イオン㈱
|
㈱マツキヨココカラ＆カンパニー
（注２）
|
— | — | — | — | — | — | — | — | — | — | — |
| Number of shares |
1,000
xbrli:shares
|
10,358
xbrli:shares
|
9,800
xbrli:shares
|
5,494
xbrli:shares
|
468,600
xbrli:shares
|
500,000
xbrli:shares
|
3,115
xbrli:shares
|
14,641
xbrli:shares
|
42,405
xbrli:shares
|
10,986
xbrli:shares
|
215,600
xbrli:shares
|
468,600
xbrli:shares
|
1,000
xbrli:shares
|
500,000
xbrli:shares
|
9,800
xbrli:shares
|
5,494
xbrli:shares
|
215,600
xbrli:shares
|
3,115
xbrli:shares
|
10,057
xbrli:shares
|
40,346
xbrli:shares
|
10,716
xbrli:shares
|
14,641
xbrli:shares
|
| Carrying amount |
16,000,000
JPY
|
37,000,000
JPY
|
108,000,000
JPY
|
19,000,000
JPY
|
921,000,000
JPY
|
312,000,000
JPY
|
13,000,000
JPY
|
7,000,000
JPY
|
36,000,000
JPY
|
29,000,000
JPY
|
918,000,000
JPY
|
985,000,000
JPY
|
17,000,000
JPY
|
295,000,000
JPY
|
139,000,000
JPY
|
17,000,000
JPY
|
1,062,000,000
JPY
|
15,000,000
JPY
|
38,000,000
JPY
|
31,000,000
JPY
|
35,000,000
JPY
|
9,000,000
JPY
|
| Whether issuer of aforementioned shares holds reporting company's shares |
無
|
無
|
無
|
有
|
有
|
無
|
無
|
無
|
無
|
無
|
無
|
— | — | — | — | — | — | — | — | — | — | — |